Since we have demonstrated the positive effects of cone vision of a rodent models of recessive and dominant RP, patients carrying a recessive mutation of the PDE6B gene (4% of all recessive RP) and those with dominant mutations in the RHO gene (25% of all dominant RP) are better suited for this phase of the project [101]. This evidence concerns the gene PDE6B and retinitis pigmentosa 1.